Related Experiment Video
Updated: Jan 7, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Interrupted sitting at work can alter postprandial glucose, triglycerides and non-esterified fatty acids (NEFA)
1Department of Community Medicine, Faculty of Medicine, Medical Campus, Universiti Sultan Zainal Abidin, Kuala Terengganu, Terengganu, Malaysia. ismunira@unisza.edu.my.
Introduction:
Prolonged sitting at work is a major health issue as sedentary behaviour has been linked to cardiometabolic risks. Workplace interventions have trialled intermittent interruption to sitting throughout the working day to mitigate effects on employees' health. This study tested effects of the intensity of the interruptions to sitting on postprandial glucose, triglycerides and NEFA in a laboratory setting.
Materials And Methods:
Overweight and obese adults (n=24) were recruited for a randomised cross over trial comparing, 1) uninterrupted sitting, 2) sitting interrupted by light intensity walking at 3 km.hr-1, and 3) vigorous intensity stair climbing at 60 steps.min-1. The interruptions to sitting were performed for two-minute bouts every 20 minutes following a meal. The moderate fat meal was provided two hours after the trial started and blood samples were collected each hour throughout the seven-hour sessions.
Results:
There was a lower postprandial peak in plasma glucose and attenuation of the NEFA reductions for stair climbing compared to uninterrupted sitting. In contrast, triglycerides were reduced postprandially following light intensity walking compared to uninterrupted sitting.
Conclusion:
Interrupted sitting with higher intensity demonstrates greater improvements postprandially.
Related Concept Videos
Metabolic States of the Body: The Postabsorptive State
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Metabolic States of the Body: The Absorptive State
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

